(Q36917670)

English

EGFR tyrosine kinase inhibitors in lung cancer: an evolving story

scientific article published on January 2008

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

title

EGFR tyrosine kinase inhibitors in lung cancer: an evolving story (English)

1 reference

stated in

Europe PubMed Central

17 August 2017

1 reference

1

Lecia V Sequist

1 reference

stated in

Europe PubMed Central

17 August 2017

Thomas J Lynch

2

1 reference

stated in

Europe PubMed Central

17 August 2017

1 January 2008

1 reference

stated in

Europe PubMed Central

17 August 2017

Annual Review of Medicine

1 reference

stated in

Europe PubMed Central

17 August 2017

59

1 reference

stated in

Europe PubMed Central

17 August 2017

429-442

1 reference

stated in

Europe PubMed Central

17 August 2017

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1141478

Identifiers

DOI

10.1146/ANNUREV.MED.59.090506.202405

1 reference

stated in

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

PubMed ID

17716025

retrieved

17 August 2017

(Q36917670)

EGFR tyrosine kinase inhibitors in lung cancer: an evolving story

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)